Top-News

Biohaven Aktie News

Aktie
WKN:  A3DVH7 ISIN:  VGG1110E1079 US-Symbol:  BHVN Branche:  Biotechnologie Land:  USA
9,55 $
-0,06 $
-0,62%
8,1948 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
722,20 Mio. €
Streubesitz
-
KGV
-
Index-Zuordnung
-

Biohaven News

03.03.25 - PR Newswire
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results PR Newswire
11.02.25 - PR Newswire
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia PR Newswire
13.01.25 - PR Newswire
Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, ...
07.01.25 - PR Newswire
Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire
16.12.24 - PR Newswire
Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates
Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for ...

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
TempraMed Technologies Ltd
0,3605 €
-20,7%
TempraMed Technologies Ltd Chart
Das 1.000% Wachstum initiiert?!
Mehr zur Aktie »